The SMRT coregulator enhances growth of estrogen receptor-α-positive breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis

Julia K. Blackmore, Sudipan Karmakar, Guowei Gu, Vaishali Chaubal, Liguo Wang, Wei Li, Carolyn L. Smith

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

TheSMRTcoregulator functions as a dual coactivatorandcorepressor for estrogen receptor-α (ERα) in a gene-specific manner, and in several studies its elevated expression correlates with poor outcome for breast cancer patients. A specific role of SMRT in breast cancer progression has not been elucidated, but SMRT knock-down limits estradiol-dependent growth of MCF-7 breast cancer cells. In this study, small-interfering RNA (siRNA) and short-hairpin RNA (shRNA) approaches were used to determine the effects of SMRT depletion on growth of ERα-positive MCF-7 and ZR-75-1 breast cancer cells, as well as the ERα-negative MDA-MB-231 breast cancer line. Depletion of SMRT inhibited growth of ERα-positive cells grown in monolayer but had no effect on growth of the ERα-negative cells. Reduced SMRT levels also negatively impacted the anchorage-independent growth of MCF-7 cells as assessed by soft agar colony formation assays. The observed growth inhibitions were due to a loss of estradiol-induced progression through the G1/S transition of the cell cycle and increased apoptosis in SMRT-depleted compared with control cells. Gene expression analyses indicated that SMRT inhibits apoptosis by a coordinated regulation of genes involved in apoptosis. Functioning as a dual coactivator for anti-apoptotic genes and corepressor for proapoptotic genes, SMRT can limit apoptosis. Together these data indicate that SMRT promotes breast cancer progression through multiple pathways leading to increased proliferation and decreased apoptosis. Copyright

Original languageEnglish (US)
Pages (from-to)3251-3261
Number of pages11
JournalEndocrinology
Volume155
Issue number9
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Estrogen Receptors
Cell Cycle
Apoptosis
Breast Neoplasms
Growth
Small Interfering RNA
Genes
Estradiol
Co-Repressor Proteins
MCF-7 Cells
Agar
Gene Expression

ASJC Scopus subject areas

  • Endocrinology

Cite this

The SMRT coregulator enhances growth of estrogen receptor-α-positive breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis. / Blackmore, Julia K.; Karmakar, Sudipan; Gu, Guowei; Chaubal, Vaishali; Wang, Liguo; Li, Wei; Smith, Carolyn L.

In: Endocrinology, Vol. 155, No. 9, 01.01.2014, p. 3251-3261.

Research output: Contribution to journalArticle

Blackmore, Julia K. ; Karmakar, Sudipan ; Gu, Guowei ; Chaubal, Vaishali ; Wang, Liguo ; Li, Wei ; Smith, Carolyn L. / The SMRT coregulator enhances growth of estrogen receptor-α-positive breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis. In: Endocrinology. 2014 ; Vol. 155, No. 9. pp. 3251-3261.
@article{2d26c12703024b5390b806bbaf8c3dc3,
title = "The SMRT coregulator enhances growth of estrogen receptor-α-positive breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis",
abstract = "TheSMRTcoregulator functions as a dual coactivatorandcorepressor for estrogen receptor-α (ERα) in a gene-specific manner, and in several studies its elevated expression correlates with poor outcome for breast cancer patients. A specific role of SMRT in breast cancer progression has not been elucidated, but SMRT knock-down limits estradiol-dependent growth of MCF-7 breast cancer cells. In this study, small-interfering RNA (siRNA) and short-hairpin RNA (shRNA) approaches were used to determine the effects of SMRT depletion on growth of ERα-positive MCF-7 and ZR-75-1 breast cancer cells, as well as the ERα-negative MDA-MB-231 breast cancer line. Depletion of SMRT inhibited growth of ERα-positive cells grown in monolayer but had no effect on growth of the ERα-negative cells. Reduced SMRT levels also negatively impacted the anchorage-independent growth of MCF-7 cells as assessed by soft agar colony formation assays. The observed growth inhibitions were due to a loss of estradiol-induced progression through the G1/S transition of the cell cycle and increased apoptosis in SMRT-depleted compared with control cells. Gene expression analyses indicated that SMRT inhibits apoptosis by a coordinated regulation of genes involved in apoptosis. Functioning as a dual coactivator for anti-apoptotic genes and corepressor for proapoptotic genes, SMRT can limit apoptosis. Together these data indicate that SMRT promotes breast cancer progression through multiple pathways leading to increased proliferation and decreased apoptosis. Copyright",
author = "Blackmore, {Julia K.} and Sudipan Karmakar and Guowei Gu and Vaishali Chaubal and Liguo Wang and Wei Li and Smith, {Carolyn L.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1210/en.2014-1002",
language = "English (US)",
volume = "155",
pages = "3251--3261",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - The SMRT coregulator enhances growth of estrogen receptor-α-positive breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis

AU - Blackmore, Julia K.

AU - Karmakar, Sudipan

AU - Gu, Guowei

AU - Chaubal, Vaishali

AU - Wang, Liguo

AU - Li, Wei

AU - Smith, Carolyn L.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - TheSMRTcoregulator functions as a dual coactivatorandcorepressor for estrogen receptor-α (ERα) in a gene-specific manner, and in several studies its elevated expression correlates with poor outcome for breast cancer patients. A specific role of SMRT in breast cancer progression has not been elucidated, but SMRT knock-down limits estradiol-dependent growth of MCF-7 breast cancer cells. In this study, small-interfering RNA (siRNA) and short-hairpin RNA (shRNA) approaches were used to determine the effects of SMRT depletion on growth of ERα-positive MCF-7 and ZR-75-1 breast cancer cells, as well as the ERα-negative MDA-MB-231 breast cancer line. Depletion of SMRT inhibited growth of ERα-positive cells grown in monolayer but had no effect on growth of the ERα-negative cells. Reduced SMRT levels also negatively impacted the anchorage-independent growth of MCF-7 cells as assessed by soft agar colony formation assays. The observed growth inhibitions were due to a loss of estradiol-induced progression through the G1/S transition of the cell cycle and increased apoptosis in SMRT-depleted compared with control cells. Gene expression analyses indicated that SMRT inhibits apoptosis by a coordinated regulation of genes involved in apoptosis. Functioning as a dual coactivator for anti-apoptotic genes and corepressor for proapoptotic genes, SMRT can limit apoptosis. Together these data indicate that SMRT promotes breast cancer progression through multiple pathways leading to increased proliferation and decreased apoptosis. Copyright

AB - TheSMRTcoregulator functions as a dual coactivatorandcorepressor for estrogen receptor-α (ERα) in a gene-specific manner, and in several studies its elevated expression correlates with poor outcome for breast cancer patients. A specific role of SMRT in breast cancer progression has not been elucidated, but SMRT knock-down limits estradiol-dependent growth of MCF-7 breast cancer cells. In this study, small-interfering RNA (siRNA) and short-hairpin RNA (shRNA) approaches were used to determine the effects of SMRT depletion on growth of ERα-positive MCF-7 and ZR-75-1 breast cancer cells, as well as the ERα-negative MDA-MB-231 breast cancer line. Depletion of SMRT inhibited growth of ERα-positive cells grown in monolayer but had no effect on growth of the ERα-negative cells. Reduced SMRT levels also negatively impacted the anchorage-independent growth of MCF-7 cells as assessed by soft agar colony formation assays. The observed growth inhibitions were due to a loss of estradiol-induced progression through the G1/S transition of the cell cycle and increased apoptosis in SMRT-depleted compared with control cells. Gene expression analyses indicated that SMRT inhibits apoptosis by a coordinated regulation of genes involved in apoptosis. Functioning as a dual coactivator for anti-apoptotic genes and corepressor for proapoptotic genes, SMRT can limit apoptosis. Together these data indicate that SMRT promotes breast cancer progression through multiple pathways leading to increased proliferation and decreased apoptosis. Copyright

UR - http://www.scopus.com/inward/record.url?scp=84907062674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907062674&partnerID=8YFLogxK

U2 - 10.1210/en.2014-1002

DO - 10.1210/en.2014-1002

M3 - Article

C2 - 24971610

AN - SCOPUS:84907062674

VL - 155

SP - 3251

EP - 3261

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 9

ER -